The prevalence of KRASG12C mutations utilizing circulating tumor DNA (ctDNA) in
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The prevalence of KRASG12C mutations utilizing circulating tumor DNA (ctDNA) in 80,911 patients with cancer.
https://meetinglibrary.asco.org/record/187796/abstract
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.